trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Translocation, Genetic D014178 20 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Osteosarcoma D012516 50 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Retinoblastoma D012175 12 associated lipids
Radiation Injuries D011832 14 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Progeria D011371 3 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Osteomalacia D010018 5 associated lipids
Neuroblastoma D009447 66 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neoplasms D009369 13 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Nasal Polyps D009298 26 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Intellectual Disability D008607 13 associated lipids
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia D007938 74 associated lipids
Leishmaniasis D007896 19 associated lipids
Keloid D007627 12 associated lipids
Chromosome Inversion D007446 1 associated lipids
Inflammation D007249 119 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypesthesia D006987 1 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Takahashi K et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. 2006 Int. J. Oncol. pmid:16391785
Bai T et al. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. 2006 Int. J. Oncol. pmid:16391806
Pazmany T and Tomasi TB The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. 2006 J. Neuroimmunol. pmid:16360884
Minetti GC et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. 2006 Nat. Med. pmid:16980968
Lee KY et al. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. 2006 J. Immunol. pmid:16365456
Ohnishi K [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. 2006 Rinsho Ketsueki pmid:16986710
Hansen KR et al. Evolutionary-conserved telomere-linked helicase genes of fission yeast are repressed by silencing factors, RNAi components and the telomere-binding protein Taz1. 2006 Nucleic Acids Res. pmid:16407326
Dowdy SC et al. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. 2006 Mol. Cancer Ther. pmid:17121923
Fischer S et al. Histone acetylation dependent allelic expression imbalance of BAPX1 in patients with the oculo-auriculo-vertebral spectrum. 2006 Hum. Mol. Genet. pmid:16407370
Saunders LR and Verdin E Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. 2006 Mol. Cancer Ther. pmid:17121924
Bieler A et al. Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. 2006 Hum. Gene Ther. pmid:16409125
Lo PK et al. Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. 2006 Cancer Biol. Ther. pmid:16410723
ChuÄ­kin IA et al. [Anti-proliferative effect of histone deacetylase inhibitors on murine embryonic stem cells]. 2006 Tsitologiia pmid:17147260
Zou B et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. 2006 Gastroenterology pmid:17087954
Anderson I Deacetylase inhibitors aid recovery in muscular dystrophy. 2006 Lancet Neurol pmid:17089447
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Uchida H et al. Human endometrial cytodifferentiation by histone deacetylase inhibitors. 2006 Hum. Cell pmid:16643606
Stefanovsky V and Moss T Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. 2006 Cell Cycle pmid:16582637
Wang Q et al. Histone deacetylation is required for orderly meiosis. 2006 Cell Cycle pmid:16582639
Magnaghi-Jaulin L and Jaulin C Histone deacetylase activity is necessary for chromosome condensation during meiotic maturation in Xenopus laevis. 2006 Chromosome Res. pmid:16628502
Pavan Kumar P et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. 2006 Mol. Cell pmid:16630892
Vinken M et al. Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. 2006 Toxicol. Sci. pmid:16531468
Gastaldi T et al. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. 2006 Carcinogenesis pmid:16537559
Tada Y et al. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. 2006 J. Natl. Cancer Inst. pmid:16537832
Bishop CL et al. Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. 2006 Mol. Cell. Biol. pmid:16537904
Gagnon JF et al. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. 2006 Clin. Cancer Res. pmid:16551870
Rebbaa A et al. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. 2006 Cell Death Differ. pmid:16557274
Zhou C et al. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. 2006 Int. J. Oncol. pmid:16773209
Zampetaki A et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. 2006 Biochem. Biophys. Res. Commun. pmid:16814255
Jüngel A et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. 2006 Ann. Rheum. Dis. pmid:16284094
Nygård M et al. Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. 2006 J. Mol. Endocrinol. pmid:16720720
Armstrong K et al. NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. 2006 Prostate pmid:16683270
Wischnewski F et al. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. 2006 Mol. Cancer Res. pmid:16687489
Yamada N et al. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. 2006 Int. J. Cancer pmid:16721789
Kim Y et al. Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. 2006 J. Steroid Biochem. Mol. Biol. pmid:16723222
Santander VS et al. Tubulin must be acetylated in order to form a complex with membrane Na(+),K (+)-ATPase and to inhibit its enzyme activity. 2006 Mol. Cell. Biochem. pmid:16733802
Kong Y et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. 2006 Circulation pmid:16735673
Dannenberg LO et al. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. 2006 Alcohol. Clin. Exp. Res. pmid:16737450
Sestáková B and Vachtenheim J Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. 2006 Folia Biol. (Praha) pmid:17116288
Balasubramaniyan V et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. 2006 Neuroscience pmid:17084985
Zhang Y et al. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. 2006 Mol. Cell. Biol. pmid:16943418
Stewart MD et al. Dynamic regulation of histone modifications in Xenopus oocytes through histone exchange. 2006 Mol. Cell. Biol. pmid:16943430
Mühlisch J et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. 2006 Oncogene pmid:16186793
Hirsch CL et al. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. 2006 Int. J. Cancer pmid:16094635
Scott SA et al. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. 2006 Leuk. Res. pmid:16043219
Hofmann A et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. 2006 Mol. Ther. pmid:16140581
Liu H et al. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219960
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
Mai A et al. Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. 2006 J. Med. Chem. pmid:17004718
Yao J et al. NF-kappaB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. 2006 Pharmacol. Res. pmid:17005413
Jung JW et al. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. 2006 Cancer Lett. pmid:16337085
van den Boom J et al. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. 2006 Int. J. Cancer pmid:16865689
Bai J et al. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. 2006 Biochem. Biophys. Res. Commun. pmid:16904634
Charrier C et al. Synthesis of rigid trichostatin A analogs as HDAC inhibitors. 2006 Bioorg. Med. Chem. Lett. pmid:16904890
Okamoto H et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). 2006 J. Atheroscler. Thromb. pmid:16908950
Claus R et al. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. 2006 J. Leukoc. Biol. pmid:17000900
Kogai T et al. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. 2006 Endocr. Relat. Cancer pmid:16954431
Tyson-Capper AJ et al. Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy. 2006 Mol. Hum. Reprod. pmid:16959971
Chen J et al. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells. 2006 Pharmazie pmid:16964716
Kim MY et al. A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16924111
Mühlethaler-Mottet A et al. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. 2006 BMC Cancer pmid:16930472
Seo H et al. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). 2006 Nat Protoc pmid:17406441
Sonnemann J et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. 2006 Int. J. Oncol. pmid:16465382
Pedram M et al. Telomere position effect and silencing of transgenes near telomeres in the mouse. 2006 Mol. Cell. Biol. pmid:16479005
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Banchio C et al. Role of histone deacetylase in the expression of CTP:phosphocholine cytidylyltransferase alpha. 2006 J. Biol. Chem. pmid:16484221
Weaver IC et al. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16484373
Fandy TE and Srivastava RK Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. 2006 Cancer Chemother. Pharmacol. pmid:16435155
Deng G et al. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. 2006 Int. J. Cancer pmid:16425274
Huang L et al. Activation of ATP-sensitive K channels protects hippocampal CA1 neurons from hypoxia by suppressing p53 expression. 2006 Neurosci. Lett. pmid:16426753
Kim IA et al. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. 2006 Clin. Cancer Res. pmid:16467109
Osborn NK et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. 2006 Clin. Gastroenterol. Hepatol. pmid:16469682
Kwon HS et al. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. 2006 Mar-Apr Biochim. Biophys. Acta pmid:16757381
Castro-Galache MD et al. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. 2007 Int. J. Biochem. Cell Biol. pmid:17588800
Nagashima T et al. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis. 2007 Mol. Hum. Reprod. pmid:17267518
Sakuma M et al. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. 2007 Cancer Sci. pmid:17270028
Liu TX et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. 2007 Nat. Med. pmid:17159988
Yoshikawa M et al. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. 2007 J. Am. Soc. Nephrol. pmid:17135397
Strobl JS et al. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. 2007 J. Parasitol. pmid:17626366
Ho AK et al. Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. 2007 Endocrinology pmid:17628002
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17679169
Xin C et al. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. 2007 Br. J. Pharmacol. pmid:17325654
Hishiki T et al. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. 2007 J. Biol. Chem. pmid:17644518
Wu Y et al. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. 2007 Reprod Sci pmid:17644810
Wang CT and Meng M [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell]. 2007 Zhonghua Yi Xue Za Zhi pmid:17650409
Tsaprouni LG et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation. 2007 Clin. Exp. Immunol. pmid:17711487
Yasukawa K et al. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts. 2007 Br. J. Dermatol. pmid:17711521
Frye M et al. Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. 2007 PLoS ONE pmid:17712411
Adcock IM et al. Epigenetic regulation of airway inflammation. 2007 Curr. Opin. Immunol. pmid:17720468
Zhong S et al. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. 2007 Oncogene pmid:17043644
Itoh Y et al. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. 2007 J. Med. Chem. pmid:17929798
Pourebrahim R et al. ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. 2007 FEBS Lett. pmid:17936758
Ondrousková E et al. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts. 2007 Leuk. Res. pmid:16930693
Bui HT et al. Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes. 2007 Reproduction pmid:17307905
Hattori N et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. 2007 Genes Cells pmid:17352742
Barr H et al. Mbd2 contributes to DNA methylation-directed repression of the Xist gene. 2007 Mol. Cell. Biol. pmid:17353271
Li B et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17360565